Cart
0
Get 20% Free Customization In This Report
Buy this report from - $2850

Europe Histopathology Services Market by Type of Examination (Surgical Specimen, Gastrointestinal Biopsy, Breast Biopsy, Lung Biopsy, Biopsy of Gynecological Cancers, Renal Biopsy, Pancreatic Biopsy, Skin Tissue Biopsy, Liver Biopsy, Nerve Biopsy, and Testicular Biopsy) - Opportunity Analysis and Industry Forecast, 2017-2023

LI_184103
Pages: 128
Feb 2018 | 1338 Views
face gplus_n
Author's : Amrita Srivastava, & Pallavi Jaiswal
Tables: 53
Charts: 12
twit_n pr_n

Europe Histopathology Services Market Overview:

The Europe Histopathology Services Market was valued at $5,583 million in 2016, and is expected to reach $8,766 million by 2023, growing at a CAGR of 6.6% from 2017 to 2023.

Histopathology is a branch of pathology, which deals with the microscopic analysis of biological tissues to detect the presence of diseased cells/tissues. It involves the study of infinitesimal changes/aberrations in tissues that are caused due to some diseases. Histopathology tests are conducted in histopathology laboratories, wherein a pathologist studies changes or abnormalities in tissues caused by a disease.

Increase in prevalence of cancer & other chronic disorders, rapid surge in geriatric population in Europe, and rise in public awareness towards disease screening drive the growth of the Europe histopathology services market. However, limitations of histopathology and dearth of pathologists & medical laboratory scientists in the UK are expected to impede the market growth. On the contrary, increase in demand for personalized medicine is expected to offer opportunities for market expansion during the forecast period.

Europe Histopathology Services Market Segmentation

The Europe histopathology services market is segmented on the basis of type of examination and country. Based on type of examination, the market is classified into surgical specimen, gastrointestinal biopsy, breast biopsy, lung biopsy, biopsy of gynecological cancers, renal biopsy, pancreatic biopsy, skin tissue biopsy, liver biopsy, nerve biopsy, testicular biopsy, and others. By country, it is analyzed across Germany, France, the UK, Spain, and rest of Europe.

Segment Review

Histopathological examination of a surgical specimen is performed when surgical resections are submitted by surgeons or non-surgeons, including medical subspecialists, dermatologists, and interventional radiologists. A surgical resection specimen is obtained via surgical removal of an entire diseased area or organ. Surgical resection procedures are often intended as definitive surgical treatment of a disease, which is pre-diagnosed or strongly suspected.

A surgical specimen undergoes histopathological examination to confirm presence of previously diagnosed disease, stage or extent of the malignant disease, to ensure that the entire diseased area has been removed, to identify the presence of unsuspected concurrent diseases, and to provide information for postoperative treatment.

Snapshot of Spain Histopathology Services Market

Spain expends around 10% of its GDP on healthcare facilities, which constitute both private and public healthcare systems in the form of hospitals, healthcare centers, and state healthcare services. The public healthcare system is used by nearly 90% of the Spaniards. The Spain histopathology services market is expected to grow at a high rate, owing to increase in number of surgical procedures that require histopathology.

The list of key players profiled in this report include Acculabs Diagnostics UK Ltd., Cellular Pathology Services Limited, Great Ormond Street Hospital (GOSH) Laboratory, HCA Laboratories UK, Laboratoire Cerba, Sonic Healthcare Limited, Spire Healthcare Group Plc, Targos Molecular Pathology GmbH, TPL Path Labs, and Unilabs Group Services.

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Analysis by type helps to understand the various types of EHRs used by healthcare providers.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

Europe Histopathology Services Market Key Segments:

By Type of Examination

  • Surgical Specimen
  • Gastrointestinal Biopsy
  • Breast Biopsy
  • Lung Biopsy
  • Biopsy of Gynecological Cancers
  • Renal Biopsy
  • Pancreatic Biopsy
  • Skin Tissue Biopsy
  • Liver Biopsy
  • Nerve Biopsy
  • Testicular Biopsy
  • Others

By Country

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
 

Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top player positioning

3.3. Market dynamics

3.3.1. Drivers

3.3.1.1. Increase in prevalence of cancer and other chronic disorders
3.3.1.2. Rapid growth in geriatric population
3.3.1.3. Rise in public awareness for disease screening

3.3.2. Restraints

3.3.2.1. Limitations of histopathology
3.3.2.2. Shortage of pathologists in the UK

3.3.3. Opportunity

3.3.3.1. Increase in demand for personalized medicine

Chapter: 4: EUROPE HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Surgical specimen

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast

4.3. Gastrointestinal biopsy

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

4.4. Breast biopsy

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast

4.5. Lung biopsy

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast

4.6. Biopsy for gynecological cancers

4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast

4.7. Renal biopsy

4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast

4.8. Pancreatic biopsy

4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast

4.9. Skin tissue biopsy

4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast

4.10. Liver biopsy

4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast

4.11. Nerve biopsy

4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast

4.12. Testicular biopsy

4.12.1. Key market trends, growth factors, and opportunities
4.12.2. Market size and forecast

4.13. Others

4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast

Chapter: 5: EUROPE HISTOPATHOLOGY SERVICES MARKET, BY COUNTRY

5.1. Overview

5.1.1. Market size and forecast

5.2. Germany

5.2.1. Market size and forecast

5.3. France

5.3.1. Market size and forecast

5.4. UK

5.4.1. Market size and forecast

5.5. Italy

5.5.1. Market size and forecast

5.6. Spain

5.6.1. Market size and forecast

5.7. Rest of Europe

5.7.1. Market size and forecast

Chapter: 6: COMPANY PROFILES

6.1. Acculabs Diagnostics UK Ltd.

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segment

6.2. Cellular Pathology Services Limited

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments

6.3. Great Ormond Street Hospital (GOSH) Laboratory

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments

6.4. HCA Laboratories UK

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segment

6.5. Laboratoire Cerba

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments

6.6. Sonic Healthcare Limited

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Business performance

6.7. Spire Healthcare Group Plc

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Business performance
6.7.4. Key strategic moves and developments

6.8. Targos Molecular Pathology GmbH

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments

6.9. TPL Path Labs

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments

6.10. Unilabs Group Services

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Key strategic moves and developments

LIST OF TABLES

TABLE 01. INCIDENCE, MORTALITY, AND PREVALENCE OF ALL CANCER TYPES IN EUROPE (EXCLUDING NON-MELANOMA SKIN CANCER), 2012
TABLE 02. AVERAGE NUMBER OF NEW CANCER CASES PER YEAR AND AGE-SPECIFIC INCIDENCE RATES PER 100,000 POPULATION IN UK, 2013-2015
TABLE 03. AVERAGE NUMBER OF CELLULAR PATHOLOGY STAFF FTE IN A LABORATORY (EXCLUDING UNCATEGORIZED STAFF)
TABLE 04. EUROPE HISTOPATHOLOGY SERVICES MARKET REVENUE, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 05. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR SURGICAL SPECIMEN, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 06. INCIDENCE AND MORTALITY OF GASTRIC CANCER IN EUROPE, 2012
TABLE 07. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR GASTROINTESTINAL BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 08. INCIDENCE AND MORTALITY OF BREAST CANCER IN EUROPE, 2012
TABLE 09. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR BREAST BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 10. INCIDENCE AND MORTALITY OF LUNG CANCER IN EUROPE, 2012
TABLE 11. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR LUNG BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 12. INCIDENCE AND MORTALITY OF OVARIAN CANCER IN EUROPE, 2012
TABLE 13. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR BIOPSY FOR GYNECOLOGICAL CANCERS, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 14. INCIDENCE AND MORTALITY OF KIDNEY CANCER IN EUROPE, 2012
TABLE 15. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR RENAL BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 16. INCIDENCE AND MORTALITY OF PANCREATIC CANCER IN EUROPE, 2012
TABLE 17. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR PANCREATIC BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 18. INCIDENCE AND MORTALITY OF MALIGNANT MELANOMA OF SKIN IN EUROPE, 2012
TABLE 19. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR SKIN TISSUE BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. INCIDENCE AND MORTALITY OF LIVER CANCER IN EUROPE, 2012
TABLE 21. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR LIVER BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 22. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR NERVE BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23. INCIDENCE AND MORTALITY OF TESTICULAR CANCER IN EUROPE, 2012
TABLE 24. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR TESTICULAR BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 25. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR OTHER EXAMINATIONS, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 26. EUROPE HISTOPATHOLOGY SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27. GERMANY HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 28. FRENCH POPULATION (% OF THE TOTAL POPULATION) BY MAJOR AGE GROUPS
TABLE 29. FRANCE HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 30. UK HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 31. ITALY HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 32. SPAIN HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 33. MID-YEAR POPULATION BY AGE GROUP AND SEX, EUROPE, 2017 (%)
TABLE 34. REST OF EUROPE HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 35. ACCULABS DIAGNOSTICS UK LTD.: COMPANY SNAPSHOT
TABLE 36. ACCULABS DIAGNOSTICS UK LTD.: SERVICES
TABLE 37. CELLULAR PATHOLOGY SERVICES LIMITED: COMPANY SNAPSHOT
TABLE 38. CELLULAR PATHOLOGY SERVICES LIMITED: SERVICES
TABLE 39. GOSH: COMPANY SNAPSHOT
TABLE 40. GOSH: SERVICES
TABLE 41. HCA LABORATORIES: COMPANY SNAPSHOT
TABLE 42. HCA LABORATORIES: SERVICES
TABLE 43. LABORATOIRE CERBA: COMPANY SNAPSHOT
TABLE 44. LABORATOIRE CERBA: SERVICES
TABLE 45. SONIC HEALTHCARE LIMITED: COMPANY SNAPSHOT
TABLE 46. SONIC HEALTHCARE LIMITED: OPERATING SEGMENTS
TABLE 47. SPIRE HEALTHCARE GROUP PLC: COMPANY SNAPSHOT
TABLE 48. TARGOS MOLECULAR PATHOLOGY GMBH: COMPANY SNAPSHOT
TABLE 49. TARGOS MOLECULAR PATHOLOGY GMBH: OPERATING SEGMENTS
TABLE 50. TPL PATH LABS: COMPANY SNAPSHOT
TABLE 51. TPL PATH LABS: SERVICES
TABLE 52. UNILABS GROUP SERVICES: COMPANY SNAPSHOT
TABLE 53. UNILABS GROUP SERVICES: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 01. EUROPE HISTOPATHOLOGY SERVICES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN GERMANY, 2015 (%)
FIGURE 04. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN FRANCE, 2015 (%)
FIGURE 05. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN UK, 2015 (%)
FIGURE 06. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN ITALY, 2015 (%)
FIGURE 07. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN SPAIN, 2015 (%)
FIGURE 08. SONIC HEALTHCARE LIMITED: NET SALES, 2015-2017 ($MILLION)
FIGURE 09. SONIC HEALTHCARE LIMITED: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 10. SONIC HEALTHCARE LIMITED: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 11. SPIRE HEALTHCARE GROUP PLC: NET SALES, 2014-2016 ($MILLION)
FIGURE 12. SPIRE HEALTHCARE GROUP PLC: REVENUE SHARE BY CUSTOMER, 2016 (%)

 

The adoption of histopathology services is expected to increase in the near future, owing to rise in prevalence of infectious diseases and cancer in the European region. Moreover, surge in demand for personalized medicine propels the market growth. The histopathology services market has gained traction among healthcare providers, as these tests help to diagnose a disease, stage or extent of a malignant disease, and identify the presence of unsuspected concurrent diseases. Moreover, these tests can be used to provide information for postoperative treatment in certain surgical procedures. In addition, rapid surge in geriatric population in Europe is anticipated to drive the market growth.

Germany is expected to dominate the Europe histopathology services market during the forecast period, followed by France.

 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Purchase Full Report of
Europe Histopathology Services Market- Opportunity Analysis and Industry Forecast, 2017-2023

  • Single User
  • $2850
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $3423
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $4774
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts